About

Chuka Boris Jenkins, MD, FACOG

Board-certified in Obstetrics & Gynecology and in Maternal-Fetal Medicine. More than two decades caring for high-risk pregnancies.

Chuka Boris Jenkins, MD, FACOG

The short version

I directed Maternal-Fetal Medicine at MedStar Harbor Hospital in Baltimore from 2001 to 2026. My clinical work focused on complicated pregnancies, including preeclampsia, fetal growth restriction, preterm birth, gestational diabetes, and placental disease.

Over more than two decades, I cared for women facing some of the most difficult decisions in pregnancy. Much of that work involved recognizing disease early, understanding what was happening, and making decisions before complications became irreversible.

I founded Inheren Medical Strategies to bring that experience to prevention.


How I got here

I earned my undergraduate degree at Howard University, attended the University of Maryland School of Medicine, and completed my Maternal-Fetal Medicine fellowship at Georgetown University.

My early academic work included first-trimester screening for preeclampsia, fetal growth restriction, and preterm birth. I worked on research involving maternal risk factors, angiogenic markers, and placental biology.

That work reinforced something I would encounter repeatedly in clinical practice: preeclampsia is not one uniform disease. Different biological processes can lead to the same diagnosis, and those differences matter when we try to prevent it.

Over the years, I became increasingly convinced that we were not doing enough with what we already knew.

Inheren grew out of that conviction.

Why prevention matters

Preeclampsia can be prevented.

The challenge is identifying which prevention strategies belong in an individual woman's care.

Clinical trials generally report average treatment effects. But women do not all develop preeclampsia through the same biological mechanisms, and they do not necessarily respond to the same interventions.

That distinction is central to my approach.

A treatment may be effective in a biologically appropriate group while appearing ineffective when studied across a population that includes many women who would not be expected to respond.

We need to understand those differences rather than dismiss useful interventions because the average result was disappointing.

Science, individualized

My approach begins with the woman's history, her underlying biology, and the evidence supporting prevention.

A previous pregnancy can tell us a great deal. So can nutritional status, metabolic health, vascular function, and other measurable factors.

The goal is to identify what can be changed before another pregnancy becomes complicated.

That may involve several prevention strategies working together rather than relying on one intervention.

Inheren is designed to help women understand that evidence, recognize what applies to them, and participate meaningfully in decisions with their clinical teams.


Beyond the clinic

My work has also included developing treatment programs for women who face substantial barriers to receiving care, as well as providing medical care in disaster and international settings.

Those experiences reinforced the importance of building practical systems that work for the people who need them.

Dr. Jenkins hosting a State Department–sponsored Colombian delegation at BRIGHT, 2024
Hosting a State Department–sponsored Colombian delegation at BRIGHT, Baltimore, 2024.

A model built from scratch

BRIGHT

Building Resilience, Inspiring Growth, Healing Together

From 2011 to 2026 I built and ran BRIGHT, a primary-care-integrated model of buprenorphine treatment for women. It paired medication with modified contingency management and a structured therapeutic alliance, delivered inside women's primary care rather than in a siloed clinic. It served roughly 200 women and ran without external grant funding.

In August 2024, at Hendrée Jones's invitation, BRIGHT hosted a State Department–sponsored Colombian delegation touring U.S. model treatment and recovery programs.

International deployments

High-acuity medicine where the infrastructure is thin.

Service in disaster and global-health settings — the work that shaped how I think about building care that reaches people the standard system misses.

Credentials

Board certification

Obstetrics & Gynecology, and Maternal-Fetal Medicine.

Licensure

Maryland medical license (D0047289). Qualified through the Interstate Medical Licensure Compact (IMLC) for expedited licensure in member states.

Academic record

More than thirty peer-reviewed publications and presentations in maternal-fetal medicine.

The work now is prevention.

After more than two decades caring for complicated pregnancies, I want to help women avoid those complications whenever possible.

That is the purpose of Inheren Medical Strategies and Preventing Preeclampsia.